These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia. Saul JP; Ross B; Schaffer MS; Beerman L; Melikian AP; Shi J; Williams J; Barbey JT; Jin J; Hinderling PH; Clin Pharmacol Ther; 2001 Mar; 69(3):145-57. PubMed ID: 11240979 [TBL] [Abstract][Full Text] [Related]
4. Sotalol: a new class III antiarrhythmic agent. Zanetti LA Clin Pharm; 1993 Dec; 12(12):883-91. PubMed ID: 8137605 [TBL] [Abstract][Full Text] [Related]
6. Sotalol: a novel beta-blocker with class III anti-arrhythmic activity. Leibowitz D J Clin Pharmacol; 1993 Jun; 33(6):508-12. PubMed ID: 8366175 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic actions of DL-sotalol in ventricular and supraventricular arrhythmias. Singh BN J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S75-90. PubMed ID: 1279313 [TBL] [Abstract][Full Text] [Related]
8. [Comments on the contribution by Prof. Dr. S. H. Hohnloser. Sotalol]. Bode-Böger SM; Böger RH; Frölich JC Internist (Berl); 1995 Jul; 36(7):744. PubMed ID: 7672927 [No Abstract] [Full Text] [Related]
9. [Effect of sotalol on systemic hemodynamics and electrophysiology in patients with life-threatening ventricular tachyarrhythmias]. Fu G; Shan J; Wille B Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):30-2. PubMed ID: 11798623 [TBL] [Abstract][Full Text] [Related]
10. Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia. Läer S; Elshoff JP; Meibohm B; Weil J; Mir TS; Zhang W; Hulpke-Wette M J Am Coll Cardiol; 2005 Oct; 46(7):1322-30. PubMed ID: 16198851 [TBL] [Abstract][Full Text] [Related]
11. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents]. Scholz H Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988 [TBL] [Abstract][Full Text] [Related]
12. Sotalol: a new agent for the treatment of ventricular arrhythmias. Samoil D; Grubb BP; Temesy-Armos PN Am J Med Sci; 1994 Jan; 307(1):49-53. PubMed ID: 8291508 [TBL] [Abstract][Full Text] [Related]
13. Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia. Saul JP; Schaffer MS; Karpawich PP; Erickson CC; Epstein MR; Melikian AP; Shi J; Karara AH; Cai B; Hinderling PH J Clin Pharmacol; 2001 Jan; 41(1):35-43. PubMed ID: 11144992 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs]. Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989 [TBL] [Abstract][Full Text] [Related]
15. [Experience with dl-sotalol in the treatment of supraventricular arrhythmia]. Trabulo M; Almeida M; Caires G; Mesquita A; Parreira L; Morgado F; Adragão P; Bonhorst D; Seabra-Gomes R Rev Port Cardiol; 1996 Oct; 15(10):725-9, 696. PubMed ID: 9115766 [TBL] [Abstract][Full Text] [Related]
16. Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome. Tanel RE; Walsh EP; Lulu JA; Saul JP Am Heart J; 1995 Oct; 130(4):791-7. PubMed ID: 7572588 [TBL] [Abstract][Full Text] [Related]
17. [Exogenous adenosine as an anti-arrhythmia agent]. Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965 [TBL] [Abstract][Full Text] [Related]